Biochemical determinants of Adriamycin toxicity in mouse liver, heart and intestine
- PMID: 1540237
- DOI: 10.1016/0006-2952(92)90250-m
Biochemical determinants of Adriamycin toxicity in mouse liver, heart and intestine
Abstract
Biochemical characteristics relevant to the differential susceptibilities of liver, heart, and intestine to acute Adriamycin toxicity were examined in female CD-1 mice with and without intravenous Adriamycin (dose range 23-30 mg/kg). The liver which, unlike heart and intestine, is relatively resistant to Adriamycin toxicity, had high levels of glutathione and glutathione peroxidase, and exhibited a sharp decline in non-protein thiol concentrations within 1-3 hr with rebound by 6 hr after Adriamycin. Covalent binding to Adriamycin or its metabolites could not account quantitatively for the loss of non-protein thiols, implicating an oxidative mechanism. No lipid peroxidation was observed in the liver, apparently due to effective utilization of antioxidant defenses. Adriamycin caused significant increases in cardiac lipid peroxides, indicative of oxidative tissue damage, which would be expected to exacerbate cardiotoxicity. However, non-protein thiol concentrations did not decrease in heart or in intestine in response to Adriamycin. Both heart and intestine had extremely low levels of glutathione peroxidase activity, which may limit glutathione utilization for protection against oxidative toxicity. The activity of DT diaphorase, which may have an activating role in Adriamycin metabolism, was high in heart and intestine and was induced 4-fold in liver in response to Adriamycin.
Similar articles
-
Oxidative damage in selenium deficient hearts on perfusion with adriamycin: protective role of glutathione peroxidase system.Cardiovasc Res. 1989 Jun;23(6):498-504. doi: 10.1093/cvr/23.6.498. Cardiovasc Res. 1989. PMID: 2590923
-
Evaluation of ambrein and epicoprostanol for their antioxidant properties: protection against adriamycin-induced free radical toxicity.Food Chem Toxicol. 2007 Sep;45(9):1614-9. doi: 10.1016/j.fct.2007.02.024. Epub 2007 Feb 28. Food Chem Toxicol. 2007. PMID: 17408835
-
The effect of copper deficiency on adriamycin toxicity.Toxicol Lett. 1991 Jul;57(2):147-58. doi: 10.1016/0378-4274(91)90141-r. Toxicol Lett. 1991. PMID: 1649500
-
Adriamycin-induced hepatic and myocardial lipid peroxidation and DNA damage, and enhanced excretion of urinary lipid metabolites in rats.Toxicology. 1995 Jan 6;95(1-3):1-9. doi: 10.1016/0300-483x(94)02867-t. Toxicology. 1995. PMID: 7825176
-
Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity.Biophys Chem. 1990 Apr;35(2-3):247-57. doi: 10.1016/0301-4622(90)80012-v. Biophys Chem. 1990. PMID: 2204444 Review.
Cited by
-
Inhibition of Urease by Hydroquinones: A Structural and Kinetic Study.Chemistry. 2022 Nov 16;28(64):e202201770. doi: 10.1002/chem.202201770. Epub 2022 Sep 22. Chemistry. 2022. PMID: 35994380 Free PMC article.
-
Doxorubicin-Loaded Mixed Micelles Using Degradable Graft and Diblock Copolymers to Enhance Anticancer Sensitivity.Cancers (Basel). 2021 Jul 29;13(15):3816. doi: 10.3390/cancers13153816. Cancers (Basel). 2021. PMID: 34359717 Free PMC article.
-
Thermodynamic and kinetic considerations for the reaction of semiquinone radicals to form superoxide and hydrogen peroxide.Free Radic Biol Med. 2010 Sep 15;49(6):919-62. doi: 10.1016/j.freeradbiomed.2010.05.009. Epub 2010 May 21. Free Radic Biol Med. 2010. PMID: 20493944 Free PMC article. Review.
-
Recombinant transforming growth factor beta 1 and beta 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin.J Exp Med. 1994 Sep 1;180(3):1047-57. doi: 10.1084/jem.180.3.1047. J Exp Med. 1994. PMID: 8064224 Free PMC article.
-
The role of active metabolites in drug toxicity.Drug Saf. 1994 Aug;11(2):114-44. doi: 10.2165/00002018-199411020-00006. Drug Saf. 1994. PMID: 7945999 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources